Emily M. Webster

Emily M. Webster

Auto-generated profile, based on publicly available information

Emily M. Webster

Division of Obstetrics and Gynecology, Division of Gynecologic Oncology, Weill Cornell Medicine, New York, NY

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in JCO Clinical Cancer Informatics
Verified
Journal Article
Closed access
EWEmily M. Webster
Emily M. Webster
MAMuhammad Danyal Ahsan
Muhammad Danyal Ahsan
LPLuiza Perez
Luiza Perez
SLSarah R. Levi
Sarah R. Levi
CTCharlene Thomas
Charlene Thomas
MFMelissa K. Frey
Melissa K. Frey
PURPOSE: Most individuals with a hereditary cancer syndrome are unaware of their genetic status due to underutilization of hereditary cancer risk assessment. Chatbots, or programs that use artificial intelligence to simulate conversation, have emerged as a promising tool in health care and, more recently, as a potential tool for genetic cancer risk assessment and counseling. Here, we evaluated the existing literature on the use of chatbots in genetic cancer risk assessment and counseling. METHODS: A systematic review was conducted using key electronic databases to identify studies which use chatbots for genetic cancer risk assessment and counseling. Eligible studies were further subjected to meta-analysis. RESULTS: Seven studies met inclusion criteria, evaluating five distinct chatbots. Three studies evaluated a chatbot that could perform genetic cancer risk assessment, one study evaluated a chatbot that offered patient counseling, and three studies included both functions. The pooled estimated completion rate for the genetic cancer risk assessment was 36.7% (95% CI, 14.8 to 65.9). Two studies included comprehensive patient characteristics, and none involved a comparison group. Chatbots varied as to the involvement of a health care provider in the process of risk assessment and counseling. CONCLUSION: Chatbots have been used to streamline genetic cancer risk assessment and counseling and hold promise for reducing barriers to genetic services. Data regarding user and nonuser characteristics are lacking, as are data regarding comparative effectiveness to usual care. Future research may consider the impact of chatbots on equitable access to genetic services.

1 January 2021 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
BZBurak Zeybek
Burak Zeybek
EWEmily Webster
Emily Webster
NPNatalia Pogosian
Natalia Pogosian
JTJoan Tymon-Rosario
Joan Tymon-Rosario
ABAlan Balch
Alan Balch
VAVaagn Andikyan
Vaagn Andikyan
Zeybek B, et al. J Gynecol Oncol. 2021 Jul;32:e87. https://doi.org/10.3802/jgo.2021.32.e87

1 January 2022 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
JLJessie Y. Li
Jessie Y. Li
CAChristopher Ke Arkfeld
Christopher Ke Arkfeld
JTJoan Tymon-Rosario
Joan Tymon-Rosario
EWEmily Webster
Emily Webster
PSPeter Schwartz
Peter Schwartz
GMGulden Menderes
Gulden Menderes
Li JY, et al. J Gynecol Oncol. 2021 Nov;33:e13. https://doi.org/10.3802/jgo.2022.33.e13

26 December 2023 in Gynecologic Oncology
Verified
Journal Article
Closed access
EWEmily M. Webster
Emily M. Webster
MAMuhammad Danyal Ahsan
Muhammad Danyal Ahsan
AKAmita Kulkarni
Amita Kulkarni
EPEmilio Peñate
Emilio Peñate
SBShanice Beaumont
Shanice Beaumont
ECEloise Chapman-Davis
Eloise Chapman-Davis

8 March 2024 in Gynecologic Oncology
Verified
Journal Article
Closed access
EWEmily M. Webster
Emily M. Webster
LPLuiza Perez
Luiza Perez
MAMuhammad Danyal Ahsan
Muhammad Danyal Ahsan
SLSarah Levi
Sarah Levi
ICIsabelle Chandler
Isabelle Chandler
MFMelissa K. Frey
Melissa K. Frey

21 January 2024 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
EWEmily M. Webster
Emily M. Webster
MAMuhammad Danyal Ahsan
Muhammad Danyal Ahsan
AMAuja McDougale
Auja McDougale
RSRavi N. Sharaf
Ravi N. Sharaf
MFMelissa K. Frey
Melissa K. Frey